Session » 3S083 ACR Abstract: Metabolic & Crystal Arthropathies: Comorbidities & Outcomes (869–874)

Date: Sunday, October 21, 2018

Time: 2:30PM-4:00PM

Meeting: 2018 ACR/ARHP Annual Meeting

2:30PM-4:00PM: Abstract Number: 871

Estimates of Diet Quality Explain Less Variability in Serum Urate Levels Than Genetic Factors

2:30PM-4:00PM: Abstract Number: 869

Failure to Reach Serum Urate Target Is Associated with Elevated Mortality in Gout

2:30PM-4:00PM: Abstract Number: 873

General Safety of Febuxostat and Allopurinol in a Cardiovascular Outcomes Study in Patients with Gout

2:30PM-4:00PM: Abstract Number: 872

Is the Serum Uric Acid Therapeutic Target Protective of Chronic Kidney Disease, Cardiovascular Disease, and Mortality for Patients with Gout? a Longitudinal Study

2:30PM-4:00PM: Abstract Number: 870

Patient-Reported Burden of Gout in 2017 from the United States

2:30PM-4:00PM: Abstract Number: 874

Preventing a Large Majority of Incident Gout Cases By Modifying Key Risk Factors: Findings from a Prospective Cohort of 44,629 Men over 26 Years

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].